[1]
B. Mofid, “The Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis: Neoadjuvant carboplatin in locally advanced bladder cancer”, Urol J, vol. 19, p. 6841, Mar. 2022.